Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population

Objective—Using the Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA)/Cooperative Research in the Region of Augsburg (KORA) database, we investigated prospectively whether increased levels of soluble E-selectin (sE-selectin), soluble intercellular adhesion molecule 1 (sICAM-1), and von Willebrand factor (vWF), all considered to be sensitive markers of endothelial dysfunction, are associated with an increased risk of incident type 2 diabetes mellitus. Methods and Results—In a case–cohort study, concentrations of adhesion molecules were measured in stored samples of 532 case subjects and 1712 noncase subjects. VWF was measured in a subsample with available plasma samples (n=191 case and 580 noncase subjects). Men and women with elevated levels of sE-selectin had a significantly increased risk of type 2 diabetes after multivariable adjustment. Hazard ratios (95% CIs) comparing tertile extremes of sE-selectin were 2.63 (1.79 to 3.88) and 1.71 (1.07 to 2.75) for men and women, respectively. Elevated levels of sICAM-1 were also associated with an increased risk of type 2 diabetes; however, the association was not independent of other diabetes risk factors including E-selectin [hazard ratio (95% CI) for tertile 3 versus tertile 1: men, 1.32 (0.89 to 1.96); women, 1.03 (0.64 to 1.67)]. In this study, vWF was not associated with risk of type 2 diabetes. Conclusions—These data support a role of endothelial dysfunction in the etiology of type 2 diabetes.

[1]  D. Rothenbacher,et al.  Determination of C-reactive protein: comparison of three high-sensitivity immunoassays. , 2003, Clinical Chemistry.

[2]  W. Barlow,et al.  Robust variance estimation for the case-cohort design. , 1994, Biometrics.

[3]  R. L. Prentice,et al.  A case-cohort design for epidemiologic cohort studies and disease prevention trials , 1986 .

[4]  A. Döring,et al.  Trends in food consumption in a south German population from 1984/85 to 1989/90: results from the WHO MONICA project Augsburg. , 1996, Annals of nutrition & metabolism.

[5]  A. Blann,et al.  Soluble markers of endothelial cell function. , 1997, Clinical hemorheology and microcirculation.

[6]  S. Coppack,et al.  Endothelial Dysfunction: Cause of the Insulin Resistance Syndrome , 1997, Diabetes.

[7]  G. Lip,et al.  Endothelial integrity, soluble adhesion molecules and platelet markers in Type 1 diabetes mellitus , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[8]  W. Koenig,et al.  Rapid Effects of Rosiglitazone Treatment on Endothelial Function and Inflammatory Biomarkers , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[9]  D. Wagner.  Cell biology of von Willebrand factor. , 1990, Annual review of cell biology.

[10]  Paul Schoenhagen,et al.  Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. , 2003, JAMA.

[11]  H. Parving,et al.  Increased serum concentration of von Willebrand factor in non-insulin dependent diabetic patients with and without diabetic nephropathy , 1995, BMJ.

[12]  M. G. Modena,et al.  Endothelial-dependent vasodilation and incidence of type 2 diabetes in a population of healthy postmenopausal women. , 2005, Diabetes care.

[13]  J. Olefsky,et al.  Kinetics of Insulin Action In Vivo: Identification of Rate-Limiting Steps , 1995, Diabetes.

[14]  G. Lowe,et al.  Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. , 2000, Clinical chemistry.

[15]  S. Yusuf,et al.  Ramipril and the development of diabetes. , 2001, JAMA.

[16]  P. Valensi,et al.  Elevated Concentrations of Soluble E-Selectin and Vascular Cell Adhesion Molecule-1 in NIDDM: Effect of intensive insulin treatment , 1998, Diabetes Care.

[17]  U. Laufs,et al.  Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. , 2001, The American journal of cardiology.

[18]  J. Tooke,et al.  Adverse endothelial function and the insulin resistance syndrome , 2000, Journal of internal medicine.

[19]  F. Logerfo,et al.  Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. , 1999, Diabetes.

[20]  B. Duncan,et al.  Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study. , 1999, Diabetes care.

[21]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[22]  E. Topol,et al.  Cell adhesion molecules in coronary artery disease. , 1994, Journal of the American College of Cardiology.

[23]  A. Folsom,et al.  Associations of Factor VIII and von Willebrand Factor with Age, Race, Sex, and Risk Factors for Atherosclerosis , 1993, Thrombosis and Haemostasis.

[24]  T. Funahashi,et al.  Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. , 2003, Diabetes care.

[25]  P. Galajda,et al.  Endothelial markers in diabetes mellitus. , 1997, Thrombosis research.

[26]  A. Donker,et al.  Endothelial dysfunction and pathogenesis of diabetic angiopathy. , 1997, Cardiovascular research.

[27]  F. Ruschitzka,et al.  High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men , 2002, Circulation.

[28]  J. Manson,et al.  Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. , 2004, JAMA.

[29]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[30]  M. Kornitzer,et al.  The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): A major international Collaboration , 1988 .

[31]  T. V. Gopal,et al.  Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. , 1993, Journal of immunology.

[32]  G. Schuler,et al.  Regular Physical Activity Improves Endothelial Function in Patients With Coronary Artery Disease by Increasing Phosphorylation of Endothelial Nitric Oxide Synthase , 2003, Circulation.

[33]  C. Meisinger,et al.  Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. , 2002, Archives of internal medicine.

[34]  J. Amado,et al.  Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. , 2005, The Journal of clinical endocrinology and metabolism.

[35]  A. E. Caballero,et al.  Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. , 2003, Obesity research.

[36]  A. Gearing,et al.  Circulating adhesion molecules in disease. , 1993, Immunology today.

[37]  P. Grant,et al.  Levels of von Willebrand Factor, Insulin Resistance Syndrome, and a Common vWF Gene Polymorphism in Non‐insulin‐dependent (Type 2) Diabetes Mellitus , 1996, Diabetic medicine : a journal of the British Diabetic Association.